SCHEDULE: Deerfield Partner Exits BiomX Board

Deerfield Management's partner, Jonathan Leff, has resigned from the board of directors of BiomX Inc., as Deerfield entities maintain a 9.99% beneficial ownership stake.

Summary

• Deerfield Management Company, L.P. and its affiliated funds (Deerfield Private Design Fund V, L.P. and Deerfield Healthcare Innovations Fund II, L.P.) collectively report a beneficial ownership of 989,056 shares of BiomX Inc. common stock.
• This represents 9.99% of the outstanding common stock, calculated based on 1,593,516 shares outstanding as of February 3, 2026.
• The beneficial ownership includes existing common stock, shares issuable upon conversion of Series X Preferred Stock, and shares underlying currently exercisable warrants.
• A "Beneficial Ownership Limitation" restricts the conversion of preferred stock or exercise of warrants if it would cause the holder's beneficial ownership to exceed 9.99% of the total outstanding common stock.
• Jonathan Leff, a partner of Deerfield Management, resigned from BiomX Inc.'s board of directors effective February 9, 2026.
• No transactions in BiomX common stock were effected by the Reporting Persons in the past 60 days.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While a board resignation from a significant investor can raise questions, the filing primarily updates beneficial ownership details without indicating a significant change in investment thesis or immediate negative implications for the company's operations.

Negatives

• The resignation of Jonathan Leff, a partner from a significant institutional investor (Deerfield Management), from the board of directors could be perceived negatively, potentially signaling a reduced level of direct engagement or confidence from this key stakeholder.

Risks

• The Beneficial Ownership Limitation of 9.99% on the conversion of Series X Preferred Stock and exercise of warrants could restrict Deerfield's ability to fully convert or exercise their holdings if it would push their aggregate ownership above this threshold, potentially limiting their upside participation or influence.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding BiomX Inc.'s operational or financial performance, focusing instead on changes in beneficial ownership and board composition.

Industry Context

StockSavvy.ai notes that institutional investor board resignations, especially from significant shareholders like Deerfield Management, are often closely watched by the market. While not inherently negative, such changes can sometimes precede shifts in investment strategy or reflect differing views on company direction. The maintenance of a 9.99% beneficial ownership, capped by a limitation, suggests a continued but potentially passive investment stance.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The resignation of a board member from a major investor could lead to questions about the company's strategic direction or investor confidence. The beneficial ownership limitation ensures that Deerfield's stake remains below a certain threshold, which could impact future voting power or influence.

Key Dates

Recommendation

The filing primarily details a change in board composition and updates beneficial ownership, without providing new financial or operational data. The resignation of a director from a key institutional investor warrants attention, but without further context on the reasons or any associated strategic shifts, a 'hold' recommendation is appropriate. Investors should monitor for any subsequent announcements or changes in Deerfield's investment posture.

Keywords

BiomX Inc., Deerfield Management, Schedule 13D, Beneficial Ownership, Board Resignation, Institutional Investor, Common Stock, Series X Preferred Stock, Warrants, Corporate Governance